Literature DB >> 23995871

High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer.

Jung-Woo Choi1, Younghye Kim, Ju-Han Lee, Young-Sik Kim.   

Abstract

Aneuploidy is a result of the abnormal expression of spindle assembly checkpoint (SAC) proteins and resulting abnormal spindle function during mitosis. High expression of cell division cycle 20 homolog (CDC20) and mitotic arrest defective protein 2 (MAD2), key components of the SAC, has been reported in various carcinomas. However, the clinicopathological significance of CDC20 and MAD2 expressions in urothelial carcinoma of the human bladder (UCB) is unknown. We therefore studied the expression of CDC20 and MAD2 in UCB specimens by immunohistochemistry. High expression of CDC20 and MAD2 was observed in 59.0 % (200/339) and 51.0 % (173/339) of UCB cases, respectively. Most high-grade tumor cells exhibited diffuse nuclear and/or cytoplasmic staining for CDC20 and MAD2, whereas most low-grade tumor cells and normal urothelial cells were not stained. CDC20 overexpression was associated with advanced age (p = 0.010), high grade (p < 0.001), advanced stage (p < 0.001), non-papillary growth pattern (p < 0.001), and distant metastasis (p = 0.042). Similarly, high MAD2 expression correlated with high grade (p < 0.001), advanced stage (p < 0.001), and non-papillary growth pattern (p < 0.001). In univariate survival analyses, high CDC20 expression correlated with shorter recurrence-free survival (RFS) (p = 0.032) and poorer overall survival (OS) (p = 0.007) in patients with UCB, whereas high MAD2 expression was associated with poorer OS (p = 0.008). In multivariate analyses, high CDC20 expression correlated with shorter RFS of patients with Ta stage UCB (hazard ratio, 1.91; p = 0.01). In conclusion, increased expression of CDC20 and MAD2 is related to poor prognosis of UCB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995871     DOI: 10.1007/s00428-013-1473-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition.

Authors:  Juan-Manuel Schvartzman; Pascal H G Duijf; Rocio Sotillo; Courtney Coker; Robert Benezra
Journal:  Cancer Cell       Date:  2011-06-14       Impact factor: 31.743

2.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

Review 3.  Cell cannibalism and cancer.

Authors:  Nidhi Sharma; Pranab Dey
Journal:  Diagn Cytopathol       Date:  2011-03       Impact factor: 1.582

4.  Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

Authors:  L A Donehower; L A Godley; C M Aldaz; R Pyle; Y P Shi; D Pinkel; J Gray; A Bradley; D Medina; H E Varmus
Journal:  Genes Dev       Date:  1995-04-01       Impact factor: 11.361

Review 5.  Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.

Authors:  Yingmei Wang; Ping Ji; Jinsong Liu; Russell R Broaddus; Fengxia Xue; Wei Zhang
Journal:  Mol Cancer       Date:  2009-02-13       Impact factor: 27.401

6.  Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.

Authors:  Shu-Hui Zhang; Ai-Min Xu; Xin-Fang Chen; Di-Hua Li; Man-Ping Sun; Yu-Jia Wang
Journal:  Hum Pathol       Date:  2008-08-20       Impact factor: 3.466

Review 7.  The spindle checkpoint, aneuploidy, and cancer.

Authors:  Rajnish Bharadwaj; Hongtao Yu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

8.  MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer.

Authors:  Li Wang; Fang Yin; Yulei Du; Wenqi Du; Bei Chen; Yongguo Zhang; Kaichun Wu; Jie Ding; Jie Liu; Daiming Fan
Journal:  Am J Clin Pathol       Date:  2009-06       Impact factor: 2.493

Review 9.  Chromosomal instability in bladder cancer.

Authors:  Andrea R Florl; Wolfgang A Schulz
Journal:  Arch Toxicol       Date:  2008-02-06       Impact factor: 5.153

10.  Identification of common differentially expressed genes in urinary bladder cancer.

Authors:  Apostolos Zaravinos; George I Lambrou; Ioannis Boulalas; Dimitris Delakas; Demetrios A Spandidos
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

View more
  46 in total

1.  Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.

Authors:  L Yang; S Feng; Y Yang
Journal:  Cancer Gene Ther       Date:  2016-11-18       Impact factor: 5.987

2.  Identification of differentially expressed protein-coding genes in lung adenocarcinomas.

Authors:  Luyao Wang; Shicheng Li; Yuanyong Wang; Zhenxue Tang; Chaolong Liu; Wenjie Jiao; Jia Liu
Journal:  Exp Ther Med       Date:  2019-12-06       Impact factor: 2.447

3.  Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach.

Authors:  Hai Huang; Qin Zhang; Chen Ye; Jian-Min Lv; Xi Liu; Lu Chen; Hao Wu; Lei Yin; Xin-Gang Cui; Dan-Feng Xu; Wen-Hui Liu
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

Review 4.  Targeting Cdc20 as a novel cancer therapeutic strategy.

Authors:  Lixia Wang; Jinfang Zhang; Lixin Wan; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Pharmacol Ther       Date:  2015-04-04       Impact factor: 12.310

5.  Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.

Authors:  Ana Vanessa Nascimento; Florence Gattacceca; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Nanomedicine (Lond)       Date:  2016-03-16       Impact factor: 5.307

6.  Lymph Node Metastases in Papillary and Medullary Thyroid Carcinoma Are Independent of Intratumoral Lymphatic Vessel Density.

Authors:  Filipe Pereira; Sofia S Pereira; Marta Mesquita; Tiago Morais; Madalena M Costa; Pedro Quelhas; Carlos Lopes; Mariana P Monteiro; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2017-03-17

7.  Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.

Authors:  Cheng Long; Juan Chen; Hua Zhou; Tao Jiang; Xiang Fang; Dong Hou; Ping Liu; Hong Duan
Journal:  Cell Cycle       Date:  2019-01-22       Impact factor: 4.534

8.  A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage.

Authors:  Mariana F Gayyed; Nehad M R Abd El-Maqsoud; Ehab Rifat Tawfiek; Saad Abdelnaby A El Gelany; Mohamed Fathy Abdel Rahman
Journal:  Tumour Biol       Date:  2015-08-06

9.  Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.

Authors:  Chen Xiong; Zhihuai Wang; Guifu Wang; Chi Zhang; Shengjie Jin; Guoqing Jiang; Dousheng Bai
Journal:  Invest New Drugs       Date:  2021-05-03       Impact factor: 3.850

10.  Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis.

Authors:  Yuduo Guo; Peng Huang; Hongwei Zhang; Chunjiang Yu; Weihai Ning
Journal:  J Mol Neurosci       Date:  2020-06-13       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.